Stock Code: 002384 Stock Short Name: DSBJ Announcement No.: 2025-029
Suzhou Dongshan Precision Manufacturing Co., Ltd.
First Quarter Report 2025
The Company and all the members of the Board of Directors hereby warrant that the content of the information disclosure istrue, accurate, complete without any misrepresentation, misleading statement or material omission.
Important note:
1. The Board of Directors, the Board of Supervisors, directors, supervisors and senior executives of the Company hereby warrantthat this quarterly report is true, accurate and complete without any misrepresentation, misleading statement or material omission,and agree to assume joint and several liabilities for this quarterly report.
2. The Principal of the Company, CFO and Accounting Supervisor hereby represent that the financial information contained in thisquarterly report is true, accurate and complete.
3. Whether the First Quarter Report has been audited
□ Yes ? No
Note:
This document is a translated version of the Chinese First Quarter Report 2025 ("2025 年第一季度报告"). In case of anydiscrepancies, the First Quarter Report 2025 published in the Chinese version shall prevail. The full Chinese First Quarter Report2025 is available at www.cninfo.com.cn.
I. Key Financial Data(I) Key Accounting Data and Financial IndicatorsDid the Company need to retrospectively adjust or restate any accounting data of prior years?
□ Yes ? No
| The reporting period | The same period of the previous year | % change | |
| Operating revenue (RMB) | 8,602,240,027.91 | 7,744,804,604.28 | 11.07% |
| Net profit attributable to shareholders of the Listed Company (RMB) | 455,862,422.17 | 289,348,487.81 | 57.55% |
| Net profit attributable to shareholders of the Listed Company after deduction of non-recurring gain or loss (RMB) | 396,749,250.19 | 261,306,973.35 | 51.83% |
| Net cash flow from operating activities (RMB) | 1,365,406,591.51 | 1,557,837,879.15 | -12.35% |
| Basic earnings per share (RMB/share) | 0.27 | 0.17 | 58.82% |
| Diluted earnings per share (RMB/share) | 0.27 | 0.17 | 58.82% |
| Weighted average return on net assets | 2.39% | 1.57% | 0.82% |
| The end of the reporting period | The end of the previous year | % Change | |
| Total assets (RMB) | 46,469,701,601.63 | 46,014,173,064.47 | 0.99% |
| Owner’s equity attributable to shareholders of the Listed Company (RMB) | 19,336,648,107.86 | 18,826,387,269.38 | 2.71% |
(II) Items and amounts of non-recurring gains or losses
? Applicable □ N/A
In RMB
| Item | Amount of the current reporting period | Remark |
| Gain or loss on disposal of non-current assets (including allowance for impairment of assets that has been written off) | -6,999,913.17 | |
| Government grants recognized in profit or loss (excluding the government grants that are closely related to the business of the Company, conform to the applicable policies of the country, are provided in accordance with the established standards, and continuously affect the Company’s profit or loss) | 73,580,114.22 | |
| Gain or loss on changes in fair value of financial assets and financial liabilities held by non-financial entities, and gain or loss on disposal of financial assets and financial liabilities, except for effective hedges held in the ordinary course of business | 2,181,370.68 | |
| Other non-operating revenues and expenses | 1,853,447.68 | |
| Less: Effect on income tax | 11,468,292.00 | |
| Effect on minority interests (exclusive of tax) | 33,555.43 | |
| Total | 59,113,171.98 | -- |
Other items of gain or loss within the meaning of non-recurring gain or loss
□ Applicable ? N/A
We do not have any other item of gain or loss within the meaning of non-recurring gains or losses.Classification of any item of non-recurring gain or loss defined by the Explanatory Announcement No. 1 on InformationDisclosure by Companies Publicly Offering Securities - Non-recurring gain or Loss as recurring profit or loss:
□ Applicable ? N/A
We have not classified any item of non-recurring gain or loss defined by the Explanatory Announcement No. 1 on InformationDisclosure by Companies Publicly Offering Securities - Non-recurring Gain or Loss as recurring gain or loss.
(III) Particulars of and reasons for changes in the key accounting data and financial indicators? Applicable □ N/A
In RMB
| Balance sheet | The end of the reporting period | The end of the previous year | % Change | Main reason |
| Notes receivable | 17,257,280.16 | 9,037,098.60 | 90.96% | Primarily due to the increase in the commercial acceptance bills received by subsidiaries during the reporting period. |
| Accounts receivable financing | 375,935,062.06 | 252,612,009.41 | 48.82% | Primarily due to the increase in the bank acceptance bills received during the reporting period. |
| Employee benefits payable | 410,979,939.72 | 597,573,087.02 | -31.23% | Primarily due to the payment in the current year of the bonuses recognized at the end of the previous year. |
| Other current liabilities | 3,125,450.35 | 5,190,838.21 | -39.79% | Primarily due to the decrease in the output tax to be recognized. |
| Long-term payables | 27,830,040.68 | 49,434,786.31 | -43.70% | Primarily due to the payment of the share purchase price made in the current period. |
| Deferred income | 799,025,509.65 | 585,933,889.89 | 36.37% | Primarily due to the increase in the government grants related to assets that are received in the current period. |
| Income statement | The current reporting period | The same period of the previous year | % Change | Main reason |
| Financial expenses | 6,941,252.81 | -5,009,091.39 | 238.57% | Primarily due to the exchange gains arising from the exchange rate changes in the same period of the previous year. |
| Other income | 77,548,707.75 | 46,010,532.22 | 68.55% | Primarily due to the increase in the government grants related to assets that are recognized in the current period. |
| Investment income (loss expressed with “-”) | -5,756,481.87 | -2,133,536.06 | -169.81% | Primarily due to the investment losses from the disposal of long-term equity investments. |
| Incl.: Investment income from associates and joint ventures | -1,997,494.01 | -1,138,774.87 | -75.41% | Primarily due to the increase in the losses from investment in associates that are recognized in the current period. |
| Gain on changes in fair value (loss expressed with “-”) | 496,253.51 | -425,001.44 | 216.77% | Primarily due to the income from the foreign exchange hedging transactions measured at fair value. |
| Credit impairment loss (loss expressed with “-”) | 7,724,293.60 | -29,221,136.72 | 126.43% | Primarily due to the accounts receivable collected in the current period, which correspondingly reduced the credit impairment losses. |
| Impairment loss on assets (loss expressed with “-”) | -29,196,211.51 | -93,518,082.87 | 68.78% | Primarily due to the decrease in the provision for impairment of inventory that is made at cost and net realizable value in the current period. |
| Gain on disposal of assets (loss expressed with “-”) | -1,902,786.17 | -6,118,647.30 | 68.90% | Primarily due to the decrease in the losses from the assets disposed of in the current period. |
| Operating profit (loss expressed with “-”) | 594,895,048.03 | 346,968,163.30 | 71.46% | Primarily due to the increase in the sales volume and gross profit and the decrease in the credit impairment losses and impairment loss on assets in the current period. |
| Non-operating revenue | 3,138,139.14 | 1,937,787.73 | 61.94% | Primarily due to the increase in the amounts that cannot be paid in the current period. |
| Non-operating expenses | 1,346,996.26 | 2,638,754.45 | -48.95% | Primarily due to the increase in donations in the same period of the previous year. |
| Profit before tax (loss expressed with “-”) | 596,686,190.91 | 346,267,196.58 | 72.32% | Primarily due to the increase in the sales volume and gross profit and the decrease in the credit impairment losses and impairment loss on assets in the current period. |
| Income tax expenses | 140,159,627.28 | 56,999,473.72 | 145.90% | Primarily due to the increase in taxable incomes in the current period. |
| Net profit (loss expressed with “-”) | 456,526,563.63 | 289,267,722.86 | 57.82% | Primarily due to the increase in the sales volume and gross profit and the decrease in the credit impairment losses and impairment loss on assets in the current period. |
| Cash flow statement | The current reporting period | The same period of the previous year | % Change | Main reason |
| Net cash flows from financing activities | 267,605,322.80 | 1,476,912,312.82 | -81.88% | Primarily due to the increase in bank loans in the same period of the previous year. |
II. Shareholder Information
(I) Total number of ordinary shareholders, number of preferred shareholders whose voting rights hadbeen restituted, and shareholding by top 10 shareholders
In shares
| Total number of ordinary shareholders at the end of the reporting period | 78,035 | Total number of preferred shareholders whose voting rights had been restituted at the end of the reporting period (if any) | 0 |
| Shareholding by top 10 shareholders (excluding shares lent through securities lending and borrowing) | |||
| Name of shareholder | Status of shareholder | Shareholding percentage (%) | Shares held | No. of non-tradable shares held | Pledge, attachment or freeze | ||||
| Status of shares | Number | ||||||||
| YUAN Yongfeng | Domestic natural person | 13.04% | 222,388,153.00 | 166,791,115.00 | Pledge | 102,990,000.00 | |||
| YUAN Yonggang | Domestic natural person | 11.85% | 202,226,196.00 | 151,669,647.00 | Pledge | 89,310,000.00 | |||
| YUAN Fugen | Domestic natural person | 3.45% | 58,796,052.00 | 0.00 | N/A | 0.00 | |||
| Hong Kong Securities Clearing Company Limited | Foreign corporation | 2.89% | 49,370,652.00 | 0.00 | N/A | 0.00 | |||
| Taiping Life Insurance Co., Ltd. – Traditional – General Insurance Product-022L-CT001 Shenzhen | Others | 1.51% | 25,811,329.00 | 0.00 | N/A | 0.00 | |||
| China Life Insurance Company – Traditional – General Insurance Product-005L-CT001 Shanghai | Others | 1.03% | 17,607,640.00 | 0.00 | N/A | 0.00 | |||
| Agricultural Bank of China Limited – CSI 500 Exchange Traded Fund | Others | 1.03% | 17,509,400.00 | 0.00 | N/A | 0.00 | |||
| China Everbright Bank - Aegon-Industrial Business Model Selection Hybrid Securities Investment Fund (LOF) | Others | 0.90% | 15,287,232.00 | 0.00 | N/A | 0.00 | |||
| LI Shaoli | Domestic natural person | 0.81% | 13,799,100.00 | 0.00 | N/A | 0.00 | |||
| New China Life Insurance Company Limited – Participating – Individual Participating – 018L-FH002 Shenzhen | Others | 0.79% | 13,502,948.00 | 0.00 | N/A | 0.00 | |||
| Shareholding by top 10 holders of tradable shares (excluding the shares lent via refinancing or under executive lock-up) | |||||||||
| Name of shareholder | No. of tradable shares held | Type and number of shares | |||||||
| Type | Number | ||||||||
| YUAN Fugen | 58,796,052.00 | RMB-denominated ordinary share | 58,796,052.00 | ||||||
| YUAN Yongfeng | 55,597,038.00 | RMB-denominated ordinary share | 55,597,038.00 | ||||||
| YUAN Yonggang | 50,556,549.00 | RMB-denominated ordinary share | 50,556,549.00 | ||||||
| Hong Kong Securities Clearing Company Limited | 49,370,652.00 | RMB-denominated ordinary share | 49,370,652.00 | ||||||
| Taiping Life Insurance Co., Ltd. – Traditional – General Insurance Product-022L-CT001 Shenzhen | 25,811,329.00 | RMB-denominated ordinary share | 25,811,329.00 | ||||||
| China Life Insurance Company – Traditional – General Insurance Product-005L-CT001 Shanghai | 17,607,640.00 | RMB-denominated ordinary share | 17,607,640.00 | ||||||
| Agricultural Bank of China Limited – CSI 500 Exchange Traded Fund | 17,509,400.00 | RMB-denominated ordinary share | 17,509,400.00 | ||||||
| China Everbright Bank - Aegon-Industrial Business Model Selection Hybrid Securities Investment Fund (LOF) | 15,287,232.00 | RMB-denominated ordinary share | 15,287,232.00 | ||||||
| LI Shaoli | 13,799,100.00 | RMB-denominated ordinary share | 13,799,100.00 | ||||||
| New China Life Insurance Company Limited – Participating – Individual Participating-018L-FH002 Shenzhen | 13,502,948.00 | RMB-denominated ordinary share | 13,502,948.00 | ||||||
| Affiliates or concert parties among the shareholders listed above | Among the shareholders listed above, YUAN Yonggang and YUAN Yongfeng are sons of YUAN Fugen, and YUAN Yongfeng is the elder brother of YUAN Yonggang. YUAN Fugen, YUAN Yongfeng and YUAN Yonggang are our actual controllers. We are not aware whether there are affiliates or concert parties within the meaning of the Administrative Measures for the Takeover of Listed Companies among other shareholders listed above. | ||||||||
| Securities margin trading conducted by top 10 shareholders (if any) | LI Shaoli, a shareholder of the Company, holds 12,997,000 shares of the Company through a customer’s margin account with GF Securities Co., Ltd. | ||||||||
Share lending by shareholders holding more than 5% of the shares, top 10 shareholders and top 10 holders of tradable ordinaryshares via refinancing
□ Applicable ? N/A
Changes in top 10 shareholders and top 10 holders of tradable ordinary shares compared with the previous period due to sharelending under refinancing/repayment
□ Applicable ? N/A
(II) Total number of preferred shareholders of the Company and shareholding by top 10 holders ofpreferred shares
□ Applicable ? N/A
III. Other Significant Information
? Applicable □ N/A
1. During the current reporting period, we achieved the sales revenue in terms of new energy business of about RMB 2.630 billion, up by about
43.79%.
2. Pursuant to the resolution adopted at the 2
ndextraordinary general meeting of shareholders of the Company in 2024, the Company decided toissue shares through private placement in a total amount of up to RMB1.5 billion (inclusive) to YUAN Yonggang and YUAN Yongfeng, the actualcontrollers of the Company, the offering proceeds received from which, after deduction of the offering costs, would be wholly used to replenish theCompany’s working capital. The base date for pricing for the shares issued shall be the announcement date of the resolution considered andadopted at the 7
th meeting of the 6
thBoard of Directors of the Company under which the issuance plan was adopted, where the issuance price isRMB11.49/share, which shall be no less than 80% of the average trading price of the Company’s shares during the 20 trading days prior to thebase date for pricing. Since the Company has completed the distribution of annual rights and interests for 2023, the issuance price of this privateplacement is adjusted from RMB11.49/share to RMB11.24/share. Pursuant to the authorization granted under the resolution adopted at the 2
nd
extraordinary general meeting of the Company in 2024, and as approved by the resolution at the 15
th meeting of the 6
thBoard of Directors and the
th
meeting for the 6
thBoard of Supervisors, the total proceeds from the issuance are adjusted from no more than RMB1.5 billion (inclusive) to nomore than RMB1.404 billion (inclusive). By now, the Company’s request for private placement has been reviewed and approved by the ListingReview Center of Shenzhen Stock Exchange on March 10, 2025, and has been approved for registration by the CSRC on April 28, 2025. We willpromptly perform our obligations of information disclosure in accordance with relevant regulations depending on subsequent progress of this event.
IV. Quarterly Financial Statements(I) Financial statements
1. Consolidated balance sheet
Prepared by: Suzhou Dongshan Precision Manufacturing Co., Ltd.
In RMB
| Item | Closing balance | Opening balance |
| Current assets: | ||
| Cash and bank balances | 7,742,906,407.53 | 7,172,331,252.29 |
| Settlement deposit | ||
| Loans to banks and other financial institutions | ||
| Financial assets held for trading | 86,541,397.44 | 78,144,342.95 |
| Derivative financial assets |
| Notes receivable | 17,257,280.16 | 9,037,098.60 |
| Accounts receivable | 6,752,247,164.13 | 7,663,458,025.49 |
| Accounts receivable financing | 375,935,062.06 | 252,612,009.41 |
| Advances to suppliers | 116,757,326.77 | 93,875,465.69 |
| Premiums receivable | ||
| Reinsurance accounts receivable | ||
| Reinsurance contract reserves receivable | ||
| Other receivables | 55,682,691.13 | 45,836,662.39 |
| Incl.: Interest receivable | ||
| Dividends receivable | ||
| Financial assets held under resale agreements | ||
| Inventories | 6,274,583,633.17 | 6,152,655,607.85 |
| Incl.: Data resources | ||
| Contract assets | ||
| Assets held for sale | ||
| Non-current assets due within one year | ||
| Other current assets | 1,054,868,006.75 | 1,209,842,283.99 |
| Total current assets | 22,476,778,969.14 | 22,677,792,748.66 |
| Non-current assets: | ||
| Loans and advances to clients | ||
| Debt investments | ||
| Other debt investments | ||
| Long-term receivable | 30,000,000.00 | 30,000,000.00 |
| Long-term equity investment | 125,277,018.51 | 155,008,795.68 |
| Investments in other equity instruments | 333,657,110.00 | 333,657,110.00 |
| Other non-current financial assets | ||
| Investment properties | 716,701.31 | 781,129.10 |
| Fixed assets | 13,354,981,400.82 | 13,595,191,232.40 |
| Construction in progress | 3,308,966,077.84 | 2,575,154,318.35 |
| Productive biological assets | ||
| Oil and gas assets | ||
| Right-of-use assets | 1,310,309,497.86 | 1,313,776,299.13 |
| Intangible assets | 941,973,911.75 | 962,594,133.34 |
| Incl.: Data resources | ||
| Development expenses | ||
| Incl.: Data resources | ||
| Goodwill | 2,119,612,220.47 | 2,119,612,220.47 |
| Long-term deferred expenses | 1,022,090,809.94 | 903,599,713.89 |
| Deferred tax assets | 834,646,071.86 | 834,450,612.08 |
| Other non-current assets | 610,691,812.13 | 512,554,751.37 |
| Total non-current assets | 23,992,922,632.49 | 23,336,380,315.81 |
| Total assets | 46,469,701,601.63 | 46,014,173,064.47 |
| Current liabilities: | ||
| Short-term borrowings | 5,011,071,751.10 | 4,810,954,130.69 |
| Borrowings from Central Bank | ||
| Borrowings from banks and other financial institutions | ||
| Financial liabilities held for trading | 71,937,448.30 | 82,922,390.17 |
| Derivative financial liabilities |
| Notes payable | 1,087,354,950.36 | 935,581,272.50 |
| Accounts payable | 9,024,916,944.63 | 9,659,268,990.43 |
| Advances from clients | ||
| Contract liabilities | 138,650,188.74 | 122,562,435.14 |
| Financial assets sold under repurchase agreements | ||
| Deposits from clients and other banks | ||
| Funds received as stock broker | ||
| Funds received as underwriter of securities | ||
| Employee benefits payable | 410,979,939.72 | 597,573,087.02 |
| Taxes payable | 445,895,346.75 | 395,772,127.76 |
| Other payables | 91,987,735.92 | 94,163,223.90 |
| Incl.: Interest payable | ||
| Dividends payable | ||
| Fees and commissions payable | ||
| Reinsurance accounts payable | ||
| Liabilities held for sale | ||
| Non-current liabilities due within one year | 2,953,856,400.36 | 2,458,987,301.36 |
| Other current liabilities | 3,125,450.35 | 5,190,838.21 |
| Total current liabilities | 19,239,776,156.23 | 19,162,975,797.18 |
| Non-current liabilities: | ||
| Provision for insurance contracts | ||
| Long-term borrowings | 4,956,717,548.71 | 5,289,187,891.33 |
| Bonds payable | ||
| Incl.: Preferred shares | ||
| Perpetual bonds | ||
| Lease liabilities | 1,374,932,544.80 | 1,351,518,837.18 |
| Long-term payables | 27,830,040.68 | 49,434,786.31 |
| Long-term employee benefits payable | ||
| Provisions | 52,728,225.76 | 58,258,872.92 |
| Deferred income | 799,025,509.65 | 585,933,889.89 |
| Deferred tax liabilities | 621,663,362.63 | 630,759,756.43 |
| Other non-current liabilities | ||
| Total non-current liabilities | 7,832,897,232.23 | 7,965,094,034.06 |
| Total liabilities | 27,072,673,388.46 | 27,128,069,831.24 |
| Owners’ equity: | ||
| Share capital | 1,705,913,710.00 | 1,705,913,710.00 |
| Other equity instruments | ||
| Incl.: Preferred shares | ||
| Perpetual bonds | ||
| Capital reserve | 7,992,284,435.83 | 7,992,284,435.83 |
| Less: Treasury shares | 74,991,696.79 | 74,991,696.79 |
| Other comprehensive income | -262,705,957.77 | -317,104,374.08 |
| Special reserve | ||
| Surplus reserve | 232,241,216.54 | 232,241,216.54 |
| General risk reserve | ||
| Retained profits | 9,743,906,400.05 | 9,288,043,977.88 |
| Total owners’ equity attributable to the parent company | 19,336,648,107.86 | 18,826,387,269.38 |
| Minority interests | 60,380,105.31 | 59,715,963.85 |
| Total owners’ equity | 19,397,028,213.17 | 18,886,103,233.23 |
| Total liabilities and owners’ equity | 46,469,701,601.63 | 46,014,173,064.47 |
Legal Representative: YUAN Yonggang CFO: WANG Xu Accounting Supervisor: ZHU Deguang
2. Consolidated income statement
In RMB
| Item | Amount of the current period | Amount of the previous period |
| I. Total operating revenue | 8,602,240,027.91 | 7,744,804,604.28 |
| Incl.: Operating revenue | 8,602,240,027.91 | 7,744,804,604.28 |
| Interest income | ||
| Premiums earned | ||
| Fee and commission income | ||
| II. Total operating costs | 8,056,258,755.19 | 7,312,430,568.81 |
| Incl.: Operating cost | 7,386,509,909.13 | 6,691,217,022.58 |
| Interest expenses | ||
| Fee and commission expenses | ||
| Surrenders | ||
| Net payments for insurance claims | ||
| Net insurance contract reserves | ||
| Policyholder dividends | ||
| Reinsurance expenses | ||
| Taxes and surcharges | 37,493,838.97 | 35,204,505.88 |
| Selling expenses | 75,172,569.57 | 74,628,448.25 |
| Administrative expenses | 274,814,509.17 | 262,972,079.64 |
| R&D expenses | 275,326,675.54 | 253,417,603.85 |
| Financial expenses | 6,941,252.81 | -5,009,091.39 |
| Incl.: Interest expenses | 100,059,283.90 | 106,270,471.95 |
| Interest income | 56,209,956.61 | 68,761,600.49 |
| Add: Other income | 77,548,707.75 | 46,010,532.22 |
| Investment income (loss expressed with “-”) | -5,756,481.87 | -2,133,536.06 |
| Incl.: Investment income from associates and joint ventures | -1,997,494.01 | -1,138,774.87 |
| Gain on derecognition of financial assets at amortized cost | ||
| Exchange gain (loss expressed with “-”) | ||
| Net exposure hedging income (loss expressed with “-”) | ||
| Gain on changes in fair value (loss expressed with “-”) | 496,253.51 | -425,001.44 |
| Credit impairment loss (loss expressed with “-”) | 7,724,293.60 | -29,221,136.72 |
| Impairment loss on assets (loss expressed with “-”) | -29,196,211.51 | -93,518,082.87 |
| Gain on disposal of assets (loss expressed with “-”) | -1,902,786.17 | -6,118,647.30 |
| III. Operating profit (loss expressed with “-”) | 594,895,048.03 | 346,968,163.30 |
| Add: Non-operating revenue | 3,138,139.14 | 1,937,787.73 |
| Less: Non-operating expenses | 1,346,996.26 | 2,638,754.45 |
| IV. Profit before tax (loss expressed with “-”) | 596,686,190.91 | 346,267,196.58 |
| Less: Income tax expenses | 140,159,627.28 | 56,999,473.72 |
| V. Net profit (loss expressed with “-”) | 456,526,563.63 | 289,267,722.86 |
| (I) Classified by continuity of operation | ||
| 1. Net profit from continuing operation (loss expressed with “-”) | 456,526,563.63 | 289,267,722.86 |
| 2. Net profit from discontinued operation (loss expressed with “-”) | ||
| (II) Classified by attribution | ||
| 1. Net profit attributable to owners of the parent company | 455,862,422.17 | 289,348,487.81 |
| 2. Profit attributable to minority interests (loss expressed with “-”) | 664,141.46 | -80,764.95 |
| VI. Other comprehensive income, net | 54,398,416.31 | -28,364,080.55 |
| Other comprehensive income attributable to owners of the parent company, net after tax | 54,398,416.31 | -28,364,080.55 |
| (I) Other comprehensive income that cannot be reclassified to profit or loss | ||
| 1. Changes arising from remeasurement of defined benefit plans | ||
| 2. Other comprehensive income that cannot be reclassified to profit or loss under equity method | ||
| 3. Change in fair value of investments in other equity instruments | ||
| 4. Change in fair value of the corporation’s credit risk | ||
| 5. Others | ||
| (II) Other comprehensive income that will be reclassified to profit or loss | 54,398,416.31 | -28,364,080.55 |
| 1. Other comprehensive income that can be reclassified to profit or loss under equity method | ||
| 2. Change in fair value of other debt investments | ||
| 3. Financial assets reclassified to other comprehensive income | ||
| 4. Provision for credit impairment of other debt investments | ||
| 5. Reserves for cash flow hedge | 22,393,227.45 | -46,340,616.69 |
| 6. Differences in translation of foreign currency financial statements | 32,005,188.86 | 17,976,536.14 |
| 7. Others | ||
| Other comprehensive income attributable to minority interests, net after tax | ||
| VII. Total comprehensive income | 510,924,979.94 | 260,903,642.31 |
| Total comprehensive income attributable to owners of the parent company | 510,260,838.48 | 260,984,407.26 |
| Total comprehensive income attributable to minority interests | 664,141.46 | -80,764.95 |
| VIII. Earnings per share: | ||
| (I) Basic earnings per share | 0.27 | 0.17 |
| (II) Diluted earnings per share | 0.27 | 0.17 |
Legal Representative: YUAN Yonggang CFO: WANG Xu Accounting Supervisor: ZHU Deguang
3. Consolidated cash flow statement
In RMB
| Item | Amount of the current period | Amount of the previous period |
| I. Cash flows from operating activities | ||
| Proceeds from sale of goods and rendering of services | 9,150,872,062.61 | 9,566,045,347.79 |
| Net increase in deposits from clients and other banks | ||
| Net increase in borrowings from Central Bank | ||
| Net increase in borrowings from other financial institutions | ||
| Proceeds from premiums under prior insurance contracts | ||
| Net proceeds from reinsurance business | ||
| Net increase in insured’s deposits and investments | ||
| Proceeds from interest, fees and commissions | ||
| Net increase in borrowings from banks and other financial institutions | ||
| Net increase in receipts under repurchase transactions |
| Net cash received as stock broker | ||
| Tax refunds received | 436,846,040.44 | 284,423,129.15 |
| Other proceeds relating to operating activities | 586,739,349.17 | 349,598,272.28 |
| Cash provided by operating activities | 10,174,457,452.22 | 10,200,066,749.22 |
| Payments for purchase of goods and receipt of services | 6,929,073,577.05 | 6,655,875,365.23 |
| Net increase in loans and advances from clients | ||
| Net increase in deposits in Central Bank and other banks | ||
| Payment of claims under prior insurance contracts | ||
| Net increase in loans to banks and other financial institutions | ||
| Payment of interest, fees and commissions | ||
| Payment of policyholder dividends | ||
| Payments to and for employees | 1,339,901,217.01 | 1,246,067,419.65 |
| Taxes paid | 120,166,503.25 | 165,222,877.75 |
| Other payments relating to operating activities | 419,909,563.40 | 575,063,207.44 |
| Cash used in operating activities | 8,809,050,860.71 | 8,642,228,870.07 |
| Net cash flows from operating activities | 1,365,406,591.51 | 1,557,837,879.15 |
| II. Cash flows from investing activities | ||
| Proceeds from disposal of investments | 38,814,660.00 | 411,437,004.71 |
| Proceeds from return on investments | 1,793,948.24 | 1,597,223.39 |
| Net proceeds from the disposal of fixed assets, intangible assets and other long-term assets | 75,956,861.76 | 14,087,434.64 |
| Net proceeds from the disposal of subsidiaries and other business entities | ||
| Other proceeds relating to investing activities | 346,373,548.26 | 1,980,782.41 |
| Cash provided by investing activities | 462,939,018.26 | 429,102,445.15 |
| Payments for the acquisition of fixed assets, intangible assets and other long-term assets | 1,096,715,411.40 | 885,104,031.28 |
| Payments for investments | 21,549,777.20 | 609,673,837.08 |
| Net increase in mortgage loans | ||
| Net Payments for the acquisition of subsidiaries and other business entities | ||
| Other cash payments relating to investing activities | 317,273,465.67 | 10,425,713.71 |
| Cash used in investing activities | 1,435,538,654.27 | 1,505,203,582.07 |
| Net cash flows from investing activities | -972,599,636.01 | -1,076,101,136.92 |
| III. Cash flows from financing activities | ||
| Proceeds from investors | ||
| Incl.: Proceeds of subsidiaries from minority shareholders’ investments | ||
| Cash receipts from borrowings | 2,333,527,224.72 | 4,023,814,434.12 |
| Other proceeds relating to financing activities | 415,320,307.41 | 47,248,276.45 |
| Cash provided by financing activities | 2,748,847,532.13 | 4,071,062,710.57 |
| Repayment of borrowings | 2,333,848,790.79 | 1,948,497,173.59 |
| Payment of distribution of dividends and profits or for interest | 80,197,102.42 | 89,439,788.65 |
| Incl.: Dividends and profits distributed by subsidiaries to minor shareholders | ||
| Other payments relating to financing activities | 67,196,316.12 | 556,213,435.51 |
| Cash used in financing activities | 2,481,242,209.33 | 2,594,150,397.75 |
| Net cash flows from financing activities | 267,605,322.80 | 1,476,912,312.82 |
| IV. Effect of exchange rate changes on cash and cash equivalents | 17,576,089.34 | -203,661,385.74 |
| V. Net increase in cash and cash equivalents | 677,988,367.64 | 1,754,987,669.31 |
| Add: Opening balance of cash and cash equivalents | 5,343,600,382.37 | 5,874,684,447.67 |
| VI. Closing balance of cash and cash equivalents | 6,021,588,750.01 | 7,629,672,116.98 |
(II) Adjustment of the opening balance of related financial statement items due to the initial adoption ofnew accounting standards since 2025
□ Applicable ? N/A
(III) Auditor’s report
Whether the First Quarter Report has been audited
□ Yes ? No
The Company’s First Quarter Report has not been audited.
Board of Directors of Suzhou Dongshan Precision Manufacturing Co., Ltd.
April 29, 2025